Hollywood super-agent casts himself as deal star 4 Apr 2024 Endeavor boss Ari Emanuel was unexpectedly humbled: some of his bonuses went unpaid because the company’s stock price has sputtered. A $13 bln sale to buyout shop Silver Lake fixes the problem. Between equity, royalties and other goodies, he stands to pocket more than $400 mln.
US antitrust push invites creative dealmaking 4 Apr 2024 Policymakers and trustbusters are eyeing new restrictions on mergers and acquisitions. In this Viewsroom podcast, Breakingviews columnists unpack some imaginative workarounds being used by companies ranging from Big Tech to fast food.
Ben & Jerry’s rocky ESG road bucks vanilla trends 4 Apr 2024 The purpose-driven ice cream brand is being scooped out of Unilever as corporate activism increasingly invites controversy. And yet the maker of flavors like Empower Mint has grown faster than its parent. Social values, especially when authentic, can mix well with financial aims.
Bob Iger now under pressure to wow with an encore 3 Apr 2024 Disney’s CEO worked some magic to stop mouthy Nelson Peltz from being elected to the board. The next trick is to fix streaming and narrow a valuation gap with Netflix. Even if Iger pulls another contract extension out of his hat, shareholders want to see a financial showstopper.
GameStop saga ends. Winner: capital markets 3 Apr 2024 The game retailer cashed in on meme stock mania, revamped management, but failed to reinvent itself. Reddit-fueled investors, eager to fight shortsellers, may just lose their shirts. It would be a costly lesson that, some broken pockets aside, the market was working all along.
TSMC’s most complex engineering task is itself 3 Apr 2024 The $625 bln chipmaker has built a monopoly in advanced semiconductors by staying in Taiwan. Now it’s expanding abroad, spurred by subsidies and US-China tensions. Despite higher costs, it can generate decent returns. The bigger challenge will be keeping its technological edge.
Ari Emanuel baits investors to swim with sharks 2 Apr 2024 The CEO of Hollywood powerhouse Endeavor agreed to a $13 bln buyout billed, via creative math, as the decade’s biggest. After separating crown jewel UFC, Endeavor is complex – and cheap. For buyer Silver Lake, expert at exploiting such aberrations, this deal is perfect chum.
An $8 bln merger wrings out oilfields’ last drops 2 Apr 2024 The oil industry has refocused on returning cash in lieu of expansion, leaving a meaner market for companies that help to drill wells. SLB’s purchase of ChampionX is a smart way to hold ground, especially since only half of promised benefits need materialize to square the math.
Tesla exacerbates valuation range anxiety 2 Apr 2024 The Model 3 maker overtook China’s BYD again, but deliveries tumbled for the first time since 2020 despite being flattered by a temporary lack of cheaper options and US rivals selling dead tech. A sluggish EV market and boss Elon Musk’s bombast justify an even bigger discount.
Soho House’s private party may prove disappointing 2 Apr 2024 Executive Chair Ron Burkle could bless a de-listing of the loss-making $1.1 bln chain of members’ clubs, which he reckons will one day generate handsome earnings. He’s only right if the new sites, like São Paulo and Bangkok, prove as popular as the older ones. It’s a gamble.
Profitability is next sacrifice at inflation altar 2 Apr 2024 Central bankers want LVMH, Pepsi and others to pay higher wages without raising prices. Bottom lines in the euro zone already have dipped to 40% of output, the lowest rate since 2020, and Big Tech accounts for most US margin growth. CEOs and investors can expect leaner times.
AI’s power surge short-circuits longer-term plans 1 Apr 2024 Data centers account for 2.5% of the US grid, and machine learning is supercharging growth. Where and how to build megaplexes consuming as much electricity as a small nuclear plant are the immediate problems, but they’re solvable. Calculating future demand is the real conundrum.
Remington deal fight is all about guns’ taboo 1 Apr 2024 Political backlash made gunmakers the orphans of capital markets, leaving the 208-year-old ammo brand to be fought over by unusual suspects: a Czech firm drawing national security scrutiny and a former insider. Investors’ retreat ensured a scrappy end for the military supplier.
Odd Washington deal creates anti-M&A synergy 28 Mar 2024 Senators on opposite ends of the political spectrum are joining forces to stop stock swaps like Capital One’s $35 bln Discover deal from being tax-free. The proposal probably wouldn’t generate much revenue. It does, however, build on the movement against corporate concentration.
Central banks’ noise helps dollar – and Joe Biden 28 Mar 2024 In February, traders’ hopes of rate cuts by the Federal Reserve sent the currency lower. But it has risen 1.8% in March, partly due to policymakers’ mixed messages. Until the fog clears, the greenback will rule forex markets. That curbs US inflation and may benefit the president.
Shein’s fast fashion comes with fast-finance risks 28 Mar 2024 Influencers and US shoppers love the online retailer, but the one product that’s not yet for sale is the company’s shares. If all goes very right, a $200 bln valuation in a mooted IPO isn’t unthinkable. Yet Shein’s business model may shift as quickly as its cut-price clothing.
Eni’s green shoots are taking time to blossom 28 Mar 2024 Italy’s $53 bln energy major trades at a discount to rivals. An overhang from Rome’s potential stake sale and falling gas prices are drags. But CEO Claudio Descalzi’s plan to raise cash by spinning off energy transition-focused business units is also yet to fully shape up.
Europe’s IPO window opens slowly for buyout barons 28 Mar 2024 CVC floated beauty retailer Douglas, whose shares fell, while EQT received a warmer welcome for skincare group Galderma. In this Viewsroom podcast, Breakingviews columnists explain how to interpret the mixed message for private equity groups sitting on $3 trln of unsold assets.
Blackstone cures two ailments in one Moderna shot 27 Mar 2024 Higher costs of capital are pressuring CEOs into tough spending decisions, while buyout shops flush with cash want to deploy it. This dynamic makes a $750 mln deal to fund a biotech project a crafty solution. The hard end of the bargain: ceding value from promising flu research.
Credit card suit takes swipe at perks programs 27 Mar 2024 A $30 bln settlement in a decades-old lawsuit will compel payment networks Visa and Mastercard to let retailers charge customers more to use certain cards – and to tell them why. As shoppers take notice, they may cool on fancy rewards programs.